These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 3087858

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Utility of high-resolution ultrasound for the diagnosis of dialysis-related amyloidosis.
    Kay J, Benson CB, Lester S, Corson JM, Pinkus GS, Lazarus JM, Owen WF.
    Arthritis Rheum; 1992 Aug; 35(8):926-32. PubMed ID: 1642657
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Abeta-2M-amyloidosis and related bone diseases.
    Kazama JJ, Yamamoto S, Takahashi N, Ito Y, Maruyama H, Narita I, Gejyo F.
    J Bone Miner Metab; 2006 Aug; 24(2):182-4. PubMed ID: 16502130
    [Abstract] [Full Text] [Related]

  • 29. Electron-microscopic and immunohistochemical study of beta-2-microglobulin-related amyloidosis.
    Nishi S, Ogino S, Maruyama Y, Honma N, Gejyo F, Morita T, Arakawa M.
    Nephron; 1990 Aug; 56(4):357-63. PubMed ID: 1706823
    [Abstract] [Full Text] [Related]

  • 30. Deposition of kappa and lambda light chains in amyloid filaments of dialysis-related amyloidosis.
    Brancaccio D, Ghiggeri GM, Braidotti P, Garberi A, Gallieni M, Bellotti V, Zoni U, Gusmano R, Coggi G.
    J Am Soc Nephrol; 1995 Oct; 6(4):1262-70. PubMed ID: 8589295
    [Abstract] [Full Text] [Related]

  • 31. [Significance of serum levels of beta-2-microglobulin in dialysis patients].
    Baldrati L, Baldrati L, Delvecchio C, Capponcini C, Docci D, Turci F, Feletti C.
    Recenti Prog Med; 1990 Sep; 81(9):561-3. PubMed ID: 2263750
    [Abstract] [Full Text] [Related]

  • 32. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
    Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, Maeda K, Seo H.
    J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Hemodialysis-related amyloidomas of bone.
    Ross LV, Ross GJ, Mesgarzadeh M, Edmonds PR, Bonakdarpour A.
    Radiology; 1991 Jan; 178(1):263-5. PubMed ID: 1984316
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pore formation by beta-2-microglobulin: a mechanism for the pathogenesis of dialysis associated amyloidosis.
    Hirakura Y, Kagan BL.
    Amyloid; 2001 Jun; 8(2):94-100. PubMed ID: 11409039
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Circulating form of beta-2-microglobulin in dialysis patients.
    Gagnon RF, Somerville P, Thomson DM.
    Am J Nephrol; 1988 Jun; 8(5):379-83. PubMed ID: 3071144
    [Abstract] [Full Text] [Related]

  • 40. Beta 2-microglobulin deposition in bone in chronic renal failure.
    Onishi S, Andress DL, Maloney NA, Coburn JW, Sherrard DJ.
    Kidney Int; 1991 May; 39(5):990-5. PubMed ID: 2067215
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.